Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Covetrus, Inc.    CVET

COVETRUS, INC.

(CVET)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Covetrus: 2Q Earnings Snapshot

08/11/2020 | 04:29pm EST

PORTLAND, Maine (AP) _ Covetrus Inc. (CVET) on Tuesday reported second-quarter net income of $54 million, after reporting a loss in the same period a year earlier.

The Portland, Maine-based company said it had net income of 40 cents per share. Earnings, adjusted for non-recurring gains, came to 19 cents per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 8 cents per share.

The animal health technology and services company posted revenue of $1.03 billion in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $900.9 million.

Covetrus shares have risen 75% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $23.09, declining slightly in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CVET at https://www.zacks.com/ap/CVET

Automated Insights, source Associated Press News

All news about COVETRUS, INC.
11/18COVETRUS, INC. : Submission of Matters to a Vote of Security Holders, Regulation..
AQ
11/10COVETRUS : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
11/10COVETRUS : 3Q Earnings Snapshot
AQ
11/10COVETRUS, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
11/10COVETRUS : Announces Financial Results for Third Quarter of 2020
AQ
11/10Covetrus Announces Financial Results for Third Quarter of 2020
GL
10/27COVETRUS : Announces Third Quarter 2020 Earnings Release Date and Conference Cal..
AQ
10/27Covetrus Announces Third Quarter 2020 Earnings Release Date and Conference Ca..
GL
10/09COVETRUS : Makes a Strategic Investment in Veterinary Study Groups, the Premier ..
BU
09/28COVETRUS : Holds Virtual VetSummit Conference - October 16-18
BU
More news
Financials (USD)
Sales 2020 4 272 M - -
Net income 2020 -23,0 M - -
Net Debt 2020 675 M - -
P/E ratio 2020 -112x
Yield 2020 -
Capitalization 3 420 M 3 420 M -
EV / Sales 2020 0,96x
EV / Sales 2021 0,88x
Nbr of Employees 5 300
Free-Float 79,0%
Chart COVETRUS, INC.
Duration : Period :
Covetrus, Inc. Technical Analysis Chart | CVET | US22304C1009 | MarketScreener
Technical analysis trends COVETRUS, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 27,00 $
Last Close Price 26,82 $
Spread / Highest target 15,6%
Spread / Average Target 0,67%
Spread / Lowest Target -25,4%
EPS Revisions
Managers
NameTitle
Benjamin C. Wolin President, Chief Executive Officer & Director
Philip A. Laskaway Chairman
Matthew J. Foulston Chief Financial Officer
Georgina Wraight President-Global Technology Solutions & EVP
Steve Palmucci Global Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
COVETRUS, INC.102.50%3 409
ABBOTT LABORATORIES25.80%193 666
MEDTRONIC PLC-2.19%149 189
BECTON, DICKINSON AND COMPANY-15.99%66 229
HOYA CORPORATION25.50%44 928
BAXTER INTERNATIONAL INC.-9.39%38 705